358 related articles for article (PubMed ID: 36556962)
41. Chronic exposure to ambient particulate matter induces gut microbial dysbiosis in a rat COPD model.
Li N; Yang Z; Liao B; Pan T; Pu J; Hao B; Fu Z; Cao W; Zhou Y; He F; Li B; Ran P
Respir Res; 2020 Oct; 21(1):271. PubMed ID: 33076910
[TBL] [Abstract][Full Text] [Related]
42. [The Relationship Between Oral Microbiota and Chronic Obstructive Pulmonary Disease].
Yang HJ; Zhang Z; Wang ZM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):54-60. PubMed ID: 36647643
[TBL] [Abstract][Full Text] [Related]
43. Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected.
Cheng J; Zhou L; Wang H
Front Cell Infect Microbiol; 2024; 14():1296295. PubMed ID: 38371298
[TBL] [Abstract][Full Text] [Related]
44. Gut microbiota and Covid-19- possible link and implications.
Dhar D; Mohanty A
Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
[TBL] [Abstract][Full Text] [Related]
45. The lung microbiome dynamics between stability and exacerbation in chronic obstructive pulmonary disease (COPD): Current perspectives.
Dima E; Kyriakoudi A; Kaponi M; Vasileiadis I; Stamou P; Koutsoukou A; Koulouris NG; Rovina N
Respir Med; 2019 Oct; 157():1-6. PubMed ID: 31450162
[TBL] [Abstract][Full Text] [Related]
46. The role of oral microbiome in respiratory health and diseases.
Pathak JL; Yan Y; Zhang Q; Wang L; Ge L
Respir Med; 2021; 185():106475. PubMed ID: 34049183
[TBL] [Abstract][Full Text] [Related]
47. Alteration of Lung and Gut Microbiota in IL-13-Transgenic Mice Simulating Chronic Asthma.
Sohn KH; Baek MG; Choi SM; Bae B; Kim RY; Kim YC; Kim HY; Yi H; Kang HR
J Microbiol Biotechnol; 2020 Dec; 30(12):1819-1826. PubMed ID: 33046682
[TBL] [Abstract][Full Text] [Related]
48. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases.
Dumas A; Bernard L; Poquet Y; Lugo-Villarino G; Neyrolles O
Cell Microbiol; 2018 Dec; 20(12):e12966. PubMed ID: 30329198
[TBL] [Abstract][Full Text] [Related]
49. Gut-Lung Microbiota in Chronic Pulmonary Diseases: Evolution, Pathogenesis, and Therapeutics.
Shi CY; Yu CH; Yu WY; Ying HZ
Can J Infect Dis Med Microbiol; 2021; 2021():9278441. PubMed ID: 34900069
[TBL] [Abstract][Full Text] [Related]
50. The possible mechanisms of the human microbiome in allergic diseases.
Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
[TBL] [Abstract][Full Text] [Related]
51. Lung microbiome mediates the progression from chronic obstructive pulmonary disease to lung cancer through inflammation.
Wang YJ; Wu SS; Chu J; Kong XY
Yi Chuan; 2021 Jan; 43(1):30-39. PubMed ID: 33509772
[TBL] [Abstract][Full Text] [Related]
52. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
[TBL] [Abstract][Full Text] [Related]
53. The Role of Non-Typeable
Weeks JR; Staples KJ; Spalluto CM; Watson A; Wilkinson TMA
Front Cell Infect Microbiol; 2021; 11():720742. PubMed ID: 34422683
[TBL] [Abstract][Full Text] [Related]
54. Early-Life Intestine Microbiota and Lung Health in Children.
Ranucci G; Buccigrossi V; de Freitas MB; Guarino A; Giannattasio A
J Immunol Res; 2017; 2017():8450496. PubMed ID: 29359170
[TBL] [Abstract][Full Text] [Related]
55. Interaction between gut microbiota dysbiosis and lung infection as gut-lung axis caused by Streptococcus suis in mouse model.
Yang W; Ansari AR; Niu X; Zou W; Lu M; Dong L; Li F; Chen Y; Yang K; Song H
Microbiol Res; 2022 Aug; 261():127047. PubMed ID: 35552098
[TBL] [Abstract][Full Text] [Related]
56. Lung microbiome: new insights into the pathogenesis of respiratory diseases.
Li R; Li J; Zhou X
Signal Transduct Target Ther; 2024 Jan; 9(1):19. PubMed ID: 38228603
[TBL] [Abstract][Full Text] [Related]
57. Effects of compound Caoshi silkworm granules on stable COPD patients and their relationship with gut microbiota: A randomized controlled trial.
Hu Y; Shi Q; Ying S; Zhu D; Chen H; Yang X; Xu J; Xu F; Tao F; Xu B
Medicine (Baltimore); 2020 May; 99(22):e20511. PubMed ID: 32481473
[TBL] [Abstract][Full Text] [Related]
58. Microbiome in Chronic Obstructive Pulmonary Disease: Role of Natural Products Against Microbial Pathogens.
Santoro A; Tomino C; Prinzi G; Cardaci V; Fini M; Macera L; Russo P; Maggi F
Curr Med Chem; 2020; 27(18):2931-2948. PubMed ID: 31838985
[TBL] [Abstract][Full Text] [Related]
59. Influence of the Lung Microbiota Dysbiosis in Chronic Obstructive Pulmonary Disease Exacerbations: The Controversial Use of Corticosteroid and Antibiotic Treatments and the Role of Eosinophils as a Disease Marker.
Toraldo DM; Conte L
J Clin Med Res; 2019 Oct; 11(10):667-675. PubMed ID: 31636780
[TBL] [Abstract][Full Text] [Related]
60. Microbiota: A Missing Link in The Pathogenesis of Chronic Lung Inflammatory Diseases.
Magryś A
Pol J Microbiol; 2021 Mar; 70(1):25-32. PubMed ID: 33815524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
